BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38661486)

  • 1. Salivary α-Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome.
    Fanella M; Cerulli Irelli E; Accinni T; Di Fabio F; Putotto C; Pulvirenti F; Bellomi FE; Di Bonaventura C; Vivacqua G
    Mov Disord Clin Pract; 2024 Apr; ():. PubMed ID: 38661486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
    Butcher NJ; Kiehl TR; Hazrati LN; Chow EW; Rogaeva E; Lang AE; Bassett AS
    JAMA Neurol; 2013 Nov; 70(11):1359-66. PubMed ID: 24018986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 22q11.2 Deletion Syndrome-Associated Parkinson's Disease.
    Boot E; Bassett AS; Marras C
    Mov Disord Clin Pract; 2019 Jan; 6(1):11-16. PubMed ID: 30746410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging and clinical features in adults with a 22q11.2 deletion at risk of Parkinson's disease.
    Butcher NJ; Marras C; Pondal M; Rusjan P; Boot E; Christopher L; Repetto GM; Fritsch R; Chow EWC; Masellis M; Strafella AP; Lang AE; Bassett AS
    Brain; 2017 May; 140(5):1371-1383. PubMed ID: 28369257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Cerebellar Abnormalities and Parkinsonism in Patients with 22q11.2 Deletion Syndrome.
    Piervincenzi C; Fanella M; Petsas N; Frascarelli M; Morano A; Accinni T; Di Fabio F; Di Bonaventura C; Berardelli A; Pantano P
    Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421857
    [No Abstract]   [Full Text] [Related]  

  • 6. Myoclonic epilepsy, parkinsonism, schizophrenia and left-handedness as common neuropsychiatric features in 22q11.2 deletion syndrome.
    Fanella M; Frascarelli M; Lambiase C; Morano A; Unolt M; Liberati N; Fattouch J; Buzzanca A; Accinni T; Ceccanti M; Viganò A; Biondi M; Colonnese C; Giallonardo AT; Di Fabio F; Pizzuti A; Di Bonaventura C; Berardelli A
    J Med Genet; 2020 Mar; 57(3):151-159. PubMed ID: 31506323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of 22q11.2 deletion syndrome in the relationship between congenital heart disease and scoliosis.
    Homans JF; de Reuver S; Heung T; Silversides CK; Oechslin EN; Houben ML; McDonald-McGinn DM; Kruyt MC; Castelein RM; Bassett AS
    Spine J; 2020 Jun; 20(6):956-963. PubMed ID: 31958577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-Related Parkinsonian Signs in Microdeletion 22q11.2.
    Boot E; Mentzel TQ; Palmer LD; van Harten PN; Marras C; Lang AE; Bassett AS
    Mov Disord; 2020 Jul; 35(7):1239-1245. PubMed ID: 32386091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychosis and movement disorders in an adolescent with 22q11.2 deletion syndrome].
    Zinkstok JR; Velders F; Rieken R; Houben M; Fiksinski A; van Amelsvoort TAMJ; Boot E
    Tijdschr Psychiatr; 2020; 62(3):229-233. PubMed ID: 32207133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac sympathetic activity in 22q11.2 deletion syndrome.
    Verschure DO; Boot E; van Amelsvoort TA; Booij J; van Eck-Smit BL; Somsen GA; Verberne HJ
    Int J Cardiol; 2016 Jun; 212():346-51. PubMed ID: 27057952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.
    Donnelly NA; Bartsch U; Moulding HA; Eaton C; Marston H; Hall JH; Hall J; Owen MJ; van den Bree MBM; Jones MW
    Elife; 2022 Aug; 11():. PubMed ID: 36039635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attention Deficit Hyperactivity Disorder Symptoms and Psychosis in 22q11.2 Deletion Syndrome.
    Niarchou M; Calkins ME; Moore TM; Tang SX; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    Schizophr Bull; 2018 Jun; 44(4):824-833. PubMed ID: 29040797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Connectivity and Emotion Recognition Impairment in Children and Adolescents with Chromosome 22q11.2 Deletion Syndrome.
    Sanders AFP; Hobbs DA; Knaus TA; Beaton EA
    J Autism Dev Disord; 2023 Oct; 53(10):4021-4034. PubMed ID: 35917023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary microR-153 and microR-223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's Disease.
    Cressatti M; Juwara L; Galindez JM; Velly AM; Nkurunziza ES; Marier S; Canie O; Gornistky M; Schipper HM
    Mov Disord; 2020 Mar; 35(3):468-477. PubMed ID: 31800144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hippocampi of children with chromosome 22q11.2 deletion syndrome have localized anterior alterations that predict severity of anxiety.
    Scott JA; Goodrich-Hunsaker N; Kalish K; Lee A; Hunsaker MR; Schumann CM; Carmichael OT; Simon TJ
    J Psychiatry Neurosci; 2016 Apr; 41(3):203-13. PubMed ID: 26599134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.